New Delhi [India], January 1 (ANI): India's bio-CNG industry is calling for assured long-term offtake arrangements, consistent policy support and faster approvals to scale decentralised plants ...

Say you want to listen in on a group of super-intelligent aliens whose language you don't understand, and whose spaceship only flies by Earth once an hour. It's not unlike what Harvard scientists and ...

Jennifer Simonson is a business journalist with a decade of experience covering entrepreneurship and small business. Drawing on her background as a founder of multiple startups, she writes for Forbes ...

Pithy yet powerful, the Instagram bio can turn a casual scroller into an engaged follower—or send them straight to the back button. Let’s dive into the do’s and don’ts of crafting a bio that actually ...

Francis Crick missed a crucial seminar in 1951, probably because he was seeing a lover. James Watson did go, failed to take notes and misremembered key details. As a result, their first model of DNA ...

Even as concern and skepticism grows over U.S. AI startup OpenAI's buildout strategy and high spending commitments, Chinese open source AI providers are escalating their competition and one has even ...

Cyclana Bio, a biotechnology company pioneering tissue-level approaches to women's health, today announced the close of a £5M pre-seed funding round, co-led by NfX and Eka VC, and including Cocoa VC, ...

The use of B-cell–depleting antibodies for autoimmune disease has been well validated with significant use of Roche Holdings AG (OTC:RHHBY) and Biogen Inc (NASDAQ:BIIB) partnered Rituxan (rituximab) ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min United BioSource Corp., which ...

This is not the place to analyze the details of former FBI Director James Comey’s indictment because we don’t know what those details are. Prosecutors will soon have to come up with a bill of ...

BERLIN, Sept 9 (Reuters) - Novartis (NOVN.S), opens new tab will acquire Tourmaline Bio (TRML.O), opens new tab for $48 per share, valuing the New York-based biopharmaceutical company at $1.4 billion ...